NCI-H2342Homo sapiens (Human)Cancer cell line

Also known as: NCIH2342, H-2342, H2342

🤖 AI SummaryBased on 6 publications

Quick Overview

Human cancer cell line for research on genetic mutations and drug sensitivity.

Detailed Summary

The NCI-H2342 cell line is a human cancer cell line derived from a tumor, though the specific tissue and disease origin remain unspecified. It is part of the Cancer Cell Line Encyclopedia (CCLE) and has been utilized in studies examining the relationship between genetic mutations and drug sensitivity. Research involving this cell line has contributed to understanding how specific mutations affect cancer progression and response to therapeutic agents. The cell line is also part of broader efforts to characterize the genomic and molecular profiles of cancer cells, aiding in the development of targeted therapies. While the exact tissue of origin is unknown, the cell line has been used in various studies to explore cancer biology and potential treatment strategies.

Research Applications

Genetic mutation analysisDrug sensitivity testingCancer biology research

Key Characteristics

Part of the Cancer Cell Line Encyclopedia (CCLE)Used in studies on genetic mutations and drug responseContributes to understanding cancer progression and treatment
Generated on 6/17/2025

Basic Information

Database IDCVCL_1549
SpeciesHomo sapiens (Human)
Tissue SourceLung[UBERON:UBERON_0002048]

Donor Information

Age55
Age CategoryAdult
SexMale
Racecaucasian

Disease Information

DiseaseLung adenocarcinoma
LineageLung
SubtypeLung Adenocarcinoma
OncoTree CodeLUAD

DepMap Information

Source TypeATCC
Source IDACH-000951_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Tyr220Cys (c.659A>G)Unspecified-PubMed=21173094

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
10
D13S317
12
D16S539
13
D18S51
17
D19S433
13,16
D21S11
31.2,32
D2S1338
19,26
D3S1358
14
D5S818
12
D7S820
10
D8S1179
14,15
FGA
20
Penta D
12
Penta E
5
TH01
9,9.3
TPOX
8,10
vWA
17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

From clinical specimens to human cancer preclinical models -- a journey the NCI-cell line database-25 years later.

Aldige C.R., Wistuba I.I., Minna J.D.

J. Cell. Biochem. 121:3986-3999(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Chemistry-first approach for nomination of personalized treatment in lung cancer.

Posner B.A., Minna J.D., Kim H.S., White M.A.

Cell 173:864-878.e29(2018).

Characterization of human cancer cell lines by reverse-phase protein arrays.

Liang H.

Cancer Cell 31:225-239(2017).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

NCI-Navy Medical Oncology Branch cell line data base.";

Carney D.N., Minna J.D., Mulshine J.L.

J. Cell. Biochem. Suppl. 24:32-91(1996).

Web Resources